Martek Chairman Leaves Amid Sale of Unit

Columbia's Martek Biosciences is selling its fluorescent detection products business for $900,000 to a newly formed company that will be owned by its chairman Henry Linsert Jr.

Linsert is stepping down from the Martek board and will be replaced as chairman by another director, Robert L. Flanagan.

Martek said in a release that sales of fluorescent markers were less than $1 million a year and were not part of its core nutritional supplements business.

By Dan Beyers  |  June 28, 2007; 12:31 PM ET  | Category:  Biotech
Previous: Carlyle Buys Allison, Cuts IPO | Next: Rydex Investments Accepts Purchase Offer

Comments

Please email us to report offensive comments.



The comments to this entry are closed.

 
 
RSS Feed
Subscribe to The Post

© 2010 The Washington Post Company